(2S)-2-[[2-(benzoyl)phenyl]amino]-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid | (S)-2-((2-Benzoylphenyl)amino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid | (S)-2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid |
(S)-2-(2-benzoylphenylamino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid | 196808-45-4 | 1fm9 |
2(S)-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl]propionic acid | 2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID | 2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid(GI 262570) |
3433GY7132 | BDBM50085044 | CAS-196808-45-4 |
CHEMBL107367 | D04132 | DSSTox_CID_27310 |
DSSTox_GSID_47310 | DSSTox_RID_82260 | DTXSID1047310 |
Farglitazar | Farglitazar (USAN/INN) | Farglitazar [USAN:INN] |
Farglitazar [USAN] | GI 262570 | GI 262570X |
GI-262570 | GI-262570X | GI262570 |
GI262570X | GTPL2672 | KBio2_002347 |
KBio2_004915 | KBio2_007483 | KBioGR_002347 |
KBioSS_002350 | L-Tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]- (9CI) | L-Tyrosine, N-(2-benzoylphenyl)-o-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl) |
L-Tyrosine, N-(2-benzoylphenyl)-o-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)- | L-tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]- | LS-184758 |
N-(o-Benzoylphenyl)-O-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-L-tyrosine | NCGC00247940-01 | NCGC00254050-01 |
O-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]-N-[2-(phenylcarbonyl)phenyl]-L-tyrosine | Q5435087 | SCHEMBL501024 |
Tox21_300218 | UNII-3433GY7132 | ZINC49639808 |
ZZCHHVUQYRMYLW-HKBQPEDESA-N | cMAP_000025 |
CAS Number | 196808-45-4 |
PubChem Compound | 170364 |
KEGG Drug | D04132 |
PharmGKB | PA165815771 |
ChemSpider | 148961 |
Wikipedia | Farglitazar |